Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Metabolic Disturbance: early-phase trial registry
3 of 6 indexed Metabolic Disturbance trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Metabolic Disturbance: 6 US clinical trials tracked, 3 recruiting.
Metabolic Disturbance is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Southern California, running 2 of these trials.
Enrollment posture brief
Registry condition metabolic-disturbance
OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Metabolic Disturbance lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Metabolic Disturbance on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Metabolic Disturbance is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Metabolic Disturbance research.
University of Southern California accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Metabolic Disturbance trials plan to enrol fewer than 100 people.
Median target enrolment is 35 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Metabolic Disturbance research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
University of Southern California
NCT04469790
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
University of New Hampshire
NCT05912348
Diet-Induced Changes in GEnetic Material
Pennington Biomedical Research Center
NCT06252922
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
University of Washington
NCT04528004
Sedentary Behavior and Health Outcomes Study
University of Southern California
NCT03153930
Cranberry Ingestion and Cycling Related Immunity and Inflammation
Appalachian State University
NCT05407701
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Metabolic Disturbance records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Metabolic Disturbance trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Metabolic Disturbance page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Metabolic Disturbance trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Southern California sponsors the most Metabolic Disturbance trials on record, review their full trial history before evaluating a specific study. See University of Southern California's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metabolic Disturbance condition card totals 6 registered trials; most-linked intervention Cranberry Juice; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.